Tekla Capital Management LLC Harpoon Therapeutics, Inc. Transaction History

Tekla Capital Management LLC

$2.53 Billion
Q2 2023

A detailed history of Tekla Capital Management LLC transactions in Harpoon Therapeutics, Inc. stock. As of the latest transaction made, Tekla Capital Management LLC holds 259,910 shares of HARP stock, worth $0. This represents 0.01% of its overall portfolio holdings.

Number of Shares

259,910

Previous 259,910 -0.0%

Holding current value

Previous $192,000 4.17%

% of portfolio

0.01%

Previous 0.01%

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 13, 2022	BUY	$3.54 - $8.08 $920,081 - $2.1 Million	259,910 New	259,910 $1.29 Million
Q1 2021 May 14, 2021	SELL	$17.65 - $24.16 $1.88 Million - $2.57 Million	-106,419 Closed	0 $0
Q3 2020 Nov 13, 2020	BUY	$11.01 - $18.52 $1.17 Million - $1.97 Million	106,419 New	106,419 $1.81 Million

Others Institutions Holding HARP

# of Institutions

Shares Held

353K

Call Options Held

Put Options Held

Telemetry Investments, L.L.C. New York, NY

93K
Shares

$0
0.11% of portfolio

View Full List

About Harpoon Therapeutics, Inc.

Ticker HARP
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 33,106,800
Description
Harpoon Therapeutics, Inc., a clinical-stage immunotherapy company, engages in the development of a novel class of T cell engagers that harness the power of the body's immune system to treat patients suffering from cancer and other diseases in the United States. The company develops tri-specific T cell activating construct (TriTAC) product candi...

More about HARP

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Tekla Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Tekla Capital Management LLC with notifications on news.

Account

Tekla Capital Management LLC Harpoon Therapeutics, Inc. Transaction History